Daniel Arias
Stock Analyst at Stifel
(5.00)
# 8
Out of 5,182 analysts
163
Total ratings
56.99%
Success rate
142.87%
Average return
Main Sectors:
Stocks Rated by Daniel Arias
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TMO Thermo Fisher Scientific | Maintains: Buy | $700 → $600 | $470.22 | +27.60% | 18 | Apr 24, 2026 | |
| TXG 10x Genomics | Maintains: Buy | $20 → $25 | $21.37 | +16.99% | 8 | Mar 2, 2026 | |
| GH Guardant Health | Maintains: Buy | $120 → $130 | $83.09 | +56.46% | 6 | Feb 20, 2026 | |
| QGEN Qiagen | Maintains: Hold | $45 → $50 | $34.02 | +46.97% | 5 | Feb 6, 2026 | |
| TECH Bio-Techne | Maintains: Hold | $60 → $65 | $53.51 | +21.47% | 12 | Feb 5, 2026 | |
| ILMN Illumina | Maintains: Buy | $135 → $155 | $126.92 | +22.12% | 17 | Jan 20, 2026 | |
| BLLN BillionToOne | Initiates: Buy | $145 | $78.23 | +85.35% | 1 | Dec 1, 2025 | |
| MTD Mettler-Toledo International | Maintains: Buy | $1,450 → $1,600 | $1,262.48 | +26.73% | 8 | Nov 10, 2025 | |
| BRKR Bruker | Maintains: Hold | $48 → $40 | $36.26 | +10.31% | 9 | Aug 5, 2025 | |
| AVTR Avantor | Maintains: Hold | $14 → $12 | $7.86 | +52.67% | 10 | Aug 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $120 → $110 | $85.18 | +29.14% | 2 | Jul 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $260 | $178.98 | +45.27% | 10 | Mar 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $11 → $9 | $0.88 | +926.11% | 2 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $6 | $6.74 | -10.98% | 2 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $45 → $65 | $51.10 | +27.20% | 2 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $332 → $360 | $300.73 | +19.71% | 16 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $163 → $151 | $114.87 | +31.45% | 20 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $11 → $10 | $3.56 | +181.29% | 2 | Feb 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $165 → $207 | $117.43 | +76.28% | 9 | Feb 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $5 | $2.82 | +77.30% | 2 | Aug 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $28 → $10 | $4.86 | +105.76% | 2 | May 31, 2022 |
Thermo Fisher Scientific
Apr 24, 2026
Maintains: Buy
Price Target: $700 → $600
Current: $470.22
Upside: +27.60%
10x Genomics
Mar 2, 2026
Maintains: Buy
Price Target: $20 → $25
Current: $21.37
Upside: +16.99%
Guardant Health
Feb 20, 2026
Maintains: Buy
Price Target: $120 → $130
Current: $83.09
Upside: +56.46%
Qiagen
Feb 6, 2026
Maintains: Hold
Price Target: $45 → $50
Current: $34.02
Upside: +46.97%
Bio-Techne
Feb 5, 2026
Maintains: Hold
Price Target: $60 → $65
Current: $53.51
Upside: +21.47%
Illumina
Jan 20, 2026
Maintains: Buy
Price Target: $135 → $155
Current: $126.92
Upside: +22.12%
BillionToOne
Dec 1, 2025
Initiates: Buy
Price Target: $145
Current: $78.23
Upside: +85.35%
Mettler-Toledo International
Nov 10, 2025
Maintains: Buy
Price Target: $1,450 → $1,600
Current: $1,262.48
Upside: +26.73%
Bruker
Aug 5, 2025
Maintains: Hold
Price Target: $48 → $40
Current: $36.26
Upside: +10.31%
Avantor
Aug 4, 2025
Maintains: Hold
Price Target: $14 → $12
Current: $7.86
Upside: +52.67%
Jul 29, 2025
Maintains: Hold
Price Target: $120 → $110
Current: $85.18
Upside: +29.14%
Mar 14, 2025
Upgrades: Buy
Price Target: $260
Current: $178.98
Upside: +45.27%
Mar 12, 2025
Maintains: Buy
Price Target: $11 → $9
Current: $0.88
Upside: +926.11%
Nov 13, 2024
Maintains: Buy
Price Target: $17 → $6
Current: $6.74
Upside: -10.98%
Nov 11, 2024
Downgrades: Hold
Price Target: $45 → $65
Current: $51.10
Upside: +27.20%
Nov 4, 2024
Maintains: Hold
Price Target: $332 → $360
Current: $300.73
Upside: +19.71%
May 30, 2024
Maintains: Buy
Price Target: $163 → $151
Current: $114.87
Upside: +31.45%
Feb 23, 2024
Maintains: Buy
Price Target: $11 → $10
Current: $3.56
Upside: +181.29%
Feb 22, 2024
Maintains: Buy
Price Target: $165 → $207
Current: $117.43
Upside: +76.28%
Aug 14, 2023
Maintains: Buy
Price Target: $9 → $5
Current: $2.82
Upside: +77.30%
May 31, 2022
Maintains: Hold
Price Target: $28 → $10
Current: $4.86
Upside: +105.76%